Prudential Financial Inc. increased its stake in shares of Aetna Inc. (NYSE:AET) by 3.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,089,269 shares of the company’s stock after purchasing an additional 38,223 shares during the quarter. Prudential Financial Inc. owned 0.33% of Aetna worth $173,205,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AET. RDL Financial Inc. grew its position in Aetna by 7.4% in the 1st quarter. RDL Financial Inc. now owns 12,915 shares of the company’s stock valued at $1,647,000 after acquiring an additional 895 shares during the last quarter. BlackRock Inc. grew its position in Aetna by 3,374.9% in the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after acquiring an additional 29,828,390 shares during the last quarter. KCG Holdings Inc. grew its position in Aetna by 287.5% in the 1st quarter. KCG Holdings Inc. now owns 26,499 shares of the company’s stock valued at $3,380,000 after acquiring an additional 19,660 shares during the last quarter. Brown Advisory Securities LLC grew its position in Aetna by 3.3% in the 1st quarter. Brown Advisory Securities LLC now owns 3,639 shares of the company’s stock valued at $465,000 after acquiring an additional 115 shares during the last quarter. Finally, Lucus Advisors LLC bought a new position in Aetna in the 1st quarter valued at $412,000. 91.06% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/prudential-financial-inc-has-173-21-million-stake-in-aetna-inc-aet/1685874.html.

Several equities analysts have commented on AET shares. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $187.00 price objective on shares of Aetna in a research report on Friday. BidaskClub downgraded Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Zacks Investment Research downgraded Aetna from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Deutsche Bank AG increased their price target on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, Royal Bank Of Canada increased their price target on Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $170.34.

Shares of Aetna Inc. (AET) traded down $0.75 during trading hours on Tuesday, hitting $176.25. The stock had a trading volume of 1,250,000 shares, compared to its average volume of 2,550,000. Aetna Inc. has a 1 year low of $107.44 and a 1 year high of $184.98. The stock has a market capitalization of $57,480.00, a PE ratio of 17.33, a price-to-earnings-growth ratio of 1.61 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The firm had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same period last year, the business posted $2.07 earnings per share. The company’s revenue for the quarter was down 5.0% compared to the same quarter last year. research analysts expect that Aetna Inc. will post 9.79 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.13%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is 36.97%.

In related news, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.